P018: Clinical availability of functional assays: Identifying assays at risk and pathways to ensure appropriate patient care

Documenti analoghi

• P051: Impact of prenatal fentanyl exposure on sterol analysis for Smith-Lemli-Opitz syndrome in newborns
  di: Ibrahim Khoja, et al.
  Pubblicazione: (2025-01-01)
• P018: Clinical availability of functional assays: Identifying assays at risk and pathways to ensure appropriate patient care
  di: Patricia Hall, et al.
  Pubblicazione: (2023-01-01)
• P003: Clinical laboratory experience of frataxin quantification in blood for the diagnosis of Friedreich ataxia*
  di: Iris Pantovich, et al.
  Pubblicazione: (2024-01-01)
• Pre-analytic decrease of phenylalanine in plasma of patients with phenylketonuria treated with pegvaliase
  di: Coleman Turgeon, et al.
  Pubblicazione: (2024-09-01)
• O03: Exploiting narrow therapeutic windows: Utility of the urine purines and pyrimidines test for molybdenum cofactor deficiency A patients*
  di: Dayebgadoh Gerald, et al.
  Pubblicazione: (2023-01-01)